Actinium Pharmaceuticals is a clinical-stage biopharmaceutical company that develops therapies for bone marrow transplants and adoptive cell therapies. Its lead product candidate is in a clinical trial for acute myeloid leukemia; the company also offers development programs for various cancer targets. Actinium Pharma collaborates with other companies to develop new therapeutics and was founded in 2000 in New York.